T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Corning
GLW
$142B
| $512M | 0.08% |
24,943,210
-75,876
| -0.3% | -$1.98M |
|
252
argenx
ARGX
$54B
| $511M | 0.08% |
3,880,174
-149,302
| -4% | -$21.9M |
|
253
Skyworks Solutions
SWKS
$10.5B
| $510M | 0.08% |
5,702,980
-893,202
| -14% | -$95.4M |
|
254
Magna International
MGA
$18.6B
| $508M | 0.08% |
15,913,018
-3,031,962
| -16% | -$140M |
|
|
RP
255
DELISTED
RealPage, Inc.
RP
| $506M | 0.08% |
9,566,076
+185,982
| +2% | +$10.6M |
|
256
Sensata Technologies
ST
$6.69B
| $502M | 0.08% |
17,364,523
-148,888
| -0.9% | -$6.43M |
|
257
Acadia Pharmaceuticals
ACAD
$4.96B
| $500M | 0.08% |
11,827,905
-1,413,109
| -11% | -$58.2M |
|
258
Boston Beer
SAM
$1.89B
| $499M | 0.08% |
1,356,246
-12,734
| -0.9% | -$4.72M |
|
259
Entergy
ETR
$49.9B
| $496M | 0.08% |
10,557,180
-4,528,446
| -30% | -$268M |
|
260
Regeneron Pharmaceuticals
REGN
$83.8B
| $492M | 0.08% |
1,007,333
+216,210
| +27% | +$89.2M |
|
261
Rollins
ROL
$17.5B
| $492M | 0.08% |
20,405,327
+733,785
| +4% | +$18.1M |
|
262
Molina Healthcare
MOH
$10.8B
| $491M | 0.08% |
3,511,424
-157,523
| -4% | -$21.1M |
|
263
Gartner
IT
$11B
| $489M | 0.08% |
4,906,205
-1,120,808
| -19% | -$154M |
|
264
Rayonier
RYN
$6.51B
| $486M | 0.08% |
22,725,477
+435,292
| +2% | +$11M |
|
265
TAL Education Group
TAL
$6.4B
| $484M | 0.08% |
9,085,397
+3,379,874
| +59% | +$182M |
|
266
CF Industries
CF
$17.7B
| $479M | 0.08% |
17,603,196
-4,599,758
| -21% | -$171M |
|
267
Ulta Beauty
ULTA
$22.2B
| $473M | 0.07% |
2,692,330
+379,928
| +16% | +$94.7M |
|
268
Lennox International
LII
$14.5B
| $470M | 0.07% |
2,584,765
-292,523
| -10% | -$67.5M |
|
|
NVRO
269
DELISTED
NEVRO CORP.
NVRO
| $466M | 0.07% |
4,663,485
+1,980,647
| +74% | +$238M |
|
270
Sherwin-Williams
SHW
$87.2B
| $463M | 0.07% |
3,021,696
-152,868
| -5% | -$27.6M |
|
271
Loews
L
$23.1B
| $462M | 0.07% |
13,256,025
+1,097,270
| +9% | +$51.7M |
|
272
TE Connectivity
TEL
$62.5B
| $452M | 0.07% |
7,172,870
-770,614
| -10% | -$65.8M |
|
273
MGM Resorts International
MGM
$11.1B
| $442M | 0.07% |
37,443,549
-16,079,440
| -30% | -$414M |
|
|
THS
274
DELISTED
Treehouse Foods
THS
| $441M | 0.07% |
9,991,414
-5,021
| -0.1% | -$216K |
|
275
Progressive
PGR
$121B
| $441M | 0.07% |
5,967,188
+15,447
| +0.3% | +$1.19M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.